Wealth Alliance Sells 340 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Wealth Alliance reduced its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 38.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 550 shares of the biotechnology company’s stock after selling 340 shares during the period. Wealth Alliance’s holdings in Axon Enterprise were worth $327,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in AXON. Prestige Wealth Management Group LLC increased its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $40,000. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $41,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp grew its holdings in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on AXON. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. JMP Securities lifted their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a report on Tuesday, February 4th. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Finally, Craig Hallum lowered Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a research note on Thursday. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $561.31.

Insiders Place Their Bets

In other news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 1,291 shares of the business’s stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total value of $829,377.13. Following the sale, the president now owns 181,892 shares of the company’s stock, valued at approximately $116,852,877.56. The trade was a 0.70 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $513.22 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market cap of $39.13 billion, a P/E ratio of 132.62, a P/E/G ratio of 5.95 and a beta of 1.05. The business’s fifty day moving average is $619.94 and its two-hundred day moving average is $517.11. Axon Enterprise, Inc. has a 52 week low of $265.32 and a 52 week high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.